genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Antidiabetic agents
New Products
Human Liver Tests
Drug Discovery
Merck Wins Tentative FDA Approval for Lusduna
News
Tissue Engineering Opens Door to Novel Type 1 Diabetes Therapy
Industry News
Lilly to Spend $850M on U.S. Capital Projects
Industry News
Novo Nordisk Eliminating 1,000 Jobs Worldwide
Industry News
Lilly Ends Development of Transition’s Diabetes Candidate TT401
Industry News
Tobira, Dong-A Sign Licensing Accords for Evogliptin, CVC
Bioprocessing
Novozymes Spins Out Albumedix
News
AstraZeneca NDA for Diabetes Combination Rebuffed by FDA
A-Lists
Top 20 Diabetes Drugs
1
2
3
4
...
11
Page 3 of 11
Scroll Up
Scroll Up
